CIK 0001082554
- Large accelerated filer
UNITED THERAPEUTICS Corp
Sign in to watch- Ticker
- UTHR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 521984749
- Phone
- +1 301-608-9292
- Business address
- 1000 SPRING ST, SILVER SPRING, MD, 20910
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $344,206,005
- in 74 filings, $343.4M under 10b5-1 plans
Net −$344,206,005. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-09-10 | Thompson Tommy G Director | Sale | −4,560 | $403.36 | $1.8M | 8,480 |
| 2025-09-10 | Thompson Tommy G Director | Exercise or conversion · Stock Option | −4,560 | 0 | ||
| 2025-09-09 | MALCOLM JAN Director | Sale | −700 | $400.29 | $280K | 520 |
| 2025-09-09 | BENKOWITZ MICHAEL PRESIDENT AND COO | Exercise or conversion 10b5-1 | +11,375 | $397.41 | $4.5M | 11,375 |
| 2025-09-09 | BENKOWITZ MICHAEL PRESIDENT AND COO | Sale 10b5-1 | −4,875 | $393.86 | $1.9M | 6,500 |
| 2025-09-09 | BENKOWITZ MICHAEL PRESIDENT AND COO | Sale 10b5-1 | −6,500 | $400.08 | $2.6M | 0 |
| 2025-09-09 | BENKOWITZ MICHAEL PRESIDENT AND COO | Exercise or conversion · Stock Options 10b5-1 | −11,375 | 158,250 | ||
| 2025-09-09 | BENKOWITZ MICHAEL PRESIDENT AND COO | Exercise or conversion · Stock Options 10b5-1 | −6,125 | 49,000 | ||
| 2025-09-09 | ROTHBLATT MARTINE A Chairperson & CEO | Exercise or conversion 10b5-1 | +8,000 | $120.26 | $962K | 8,130 |
| 2025-09-09 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −6,165 | $398.29 | $2.5M | 1,965 |
| 2025-09-09 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,835 | $399.43 | $733K | 130 |
| 2025-09-09 | ROTHBLATT MARTINE A Chairperson & CEO | Exercise or conversion · Stock Option 10b5-1 | −8,000 | 286,000 | ||
| 2025-09-08 | BENKOWITZ MICHAEL PRESIDENT AND COO | Exercise or conversion 10b5-1 | +3,250 | $135.42 | $440K | 3,250 |
| 2025-09-08 | BENKOWITZ MICHAEL PRESIDENT AND COO | Sale 10b5-1 | −417 | $389.81 | $163K | 2,833 |
| 2025-09-08 | BENKOWITZ MICHAEL PRESIDENT AND COO | Sale 10b5-1 | −1,000 | $391.16 | $391K | 1,833 |
| 2025-09-08 | BENKOWITZ MICHAEL PRESIDENT AND COO | Sale 10b5-1 | −1,100 | $392.18 | $431K | 733 |
| 2025-09-08 | BENKOWITZ MICHAEL PRESIDENT AND COO | Sale 10b5-1 | −300 | $394.08 | $118K | 433 |
| 2025-09-08 | BENKOWITZ MICHAEL PRESIDENT AND COO | Sale 10b5-1 | −233 | $395.03 | $92K | 200 |
| 2025-09-08 | BENKOWITZ MICHAEL PRESIDENT AND COO | Sale 10b5-1 | −200 | $396.23 | $79K | 0 |
| 2025-09-08 | BENKOWITZ MICHAEL PRESIDENT AND COO | Exercise or conversion 10b5-1 | +1,750 | $146.03 | $256K | 1,750 |
Page 203 of 214 · 4,273 trades